Patent · US Active

Hydrophilic antibody-drug conjugates

US10933112B2 · kind B2 · utility

3Cited by
1References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 17, 2015
Grant dateMar 2, 2021
Priority date—
Expiry dateSep 4, 2036

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/55
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Hydrophilic Linkers, Drug-Linker compounds, Drug-Ligand Conjugate compounds and Ligand-Linkers and methods of making and using the same are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.